PUR-WASH (water) by Otsuka is insulin, including insulin aspart products, is the regulation of glucose metabolism. Approved for glycemic control in adults. First approved in 2011.
Drug data last refreshed 14h ago · AI intelligence enriched 1w ago
PUR-WASH is an ophthalmic solution containing water approved by the FDA in 2011 for glycemic control in adults. Despite its generic name and formulation, the product data indicates insulin mechanism of action for glucose metabolism regulation. The clinical utility and market positioning of a water-based ophthalmic solution for systemic glucose control warrant careful evaluation.
Product is in peak commercial stage with moderate competitive pressure (30/100), but absence of spending data and zero linked jobs suggest limited commercial team expansion opportunities.
insulin, including insulin aspart products, is the regulation of glucose metabolism. Insulin and its analogs lower blood glucose by stimulating peripheral glucose uptake, especially by skeletal muscle and fat, and by inhibiting hepatic glucose production. Insulin inhibits lipolysis and proteolysis,…
Effects of Increased Water Intake on Hormonal Response, Hydration Status, and Physical Function in Low-drinking Older Adults
A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity
Wastewater Surveillance for Carbapenem-Resistant Organism Outbreak Prediction in a Chinese Tertiary Hospital
WATER IV PCa (AS Sub-study)
Rural Water Filtration and Health Study
Worked on PUR-WASH at Otsuka? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moZero linked job openings and peak lifecycle stage with significant generic pressure indicate a mature, stable commercial environment with limited growth trajectory. Career opportunities on PUR-WASH likely involve defensive market share protection and operational efficiency rather than expansion roles.